Exercise as an Modulator of Immunological Risk Factors for Osteoporosis

Completed · Not applicable

Conditions studied: Osteoporosis

In brief

This is the second phase of a study designed to determine the immunological effects of long-term exercise on risk factors for ischemic heart disease (phase 1) and osteoporosis (phase 2). The results indicate that six months of moderate intensity exercise reduces bone resorption and increases the secretion of anti-osteoclastogenic cytokines by peripheral blood mononuclear cells.

Key facts

Study ID

NCT02765945

Run by

East Tennessee State University

People needed

43

Starts

1996-12-01

Expected to finish

1998-04-01

Last updated by the study team

2016-05-09

Who can join

Age: 30 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Normal exercise treadmill test

You may not qualify if…

• Any medical condition that would prevent participation in a six month exercise program

Where it is running

• James H. Quillen College of Medicine — Johnson City, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.